Showing results (391-400 of 14,086) with videos related to

Sort By:
Pageof 1,409
Gynecologic Oncology|October 13, 2006
Expression of class III beta tubulin in cervical cancer patients administered preoperative radiochemotherapy: correlation with response to treatment and clinical outcomeGabriella Ferrandina, Enrica Martinelli, Gian Franco Zannoni, et al.
Gynecologic Oncology|June 6, 2006
Prospective endometrial assessment of breast cancer patients treated with third generation aromatase inhibitorsGiancarlo Garuti, Fulvia Cellani, Giovanna Centinaio, et al.
Gynecologic Oncology|May 23, 2006
Phase II study of oxaliplatin as second-line chemotherapy in endometrial carcinoma: a Gynecologic Oncology Group studyPaula M Fracasso, John A Blessing, Kelly L Molpus, et al.
Gynecologic Oncology|October 20, 2006
PDGFR-alpha as a potential therapeutic target in uterine sarcomasS F Adams, J A Hickson, J Y Hutto, et al.
Gynecologic Oncology|November 25, 2006
Association between a functional single nucleotide polymorphism in the MDM2 gene and sporadic endometrial cancer riskChristine S Walsh, Carl W Miller, Beth Y Karlan, et al.
Gynecologic Oncology|May 30, 2006
Advanced cervical cancer treatment in Harris County: pilot evaluation of factors that prevent optimal therapyLois M Ramondetta, Charlotte Sun, Lisa Hollier, et al.
Gynecologic Oncology|May 16, 2006
Pathological characteristics of cervical adenocarcinoma in a multi-center US-based studySophia S Wang, Mark E Sherman, Steven G Silverberg, et al.
Gynecologic Oncology|July 11, 2006
Comparison of recurrence after vulvectomy and lymphadenectomy with and without sentinel node biopsy in early stage vulvar cancerJosé M Martínez-Palones, María A Pérez-Benavente, Antonio Gil-Moreno, et al.
Gynecologic Oncology|July 11, 2006
The value of preoperative platelet count in the prediction of cervical involvement and poor prognostic variables in patients with endometrial carcinomaAli Ayhan, Gurkan Bozdag, Cagatay Taskiran, et al.
Gynecologic Oncology|July 11, 2006
Testing of two binary grading systems for FIGO stage III serous carcinoma of the ovary and peritoneumJeffrey D Seidman, Iren Horkayne-Szakaly, Jonathan A Cosin, et al.
Pageof 1,409